Featured ArticlesGlobal Health

Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?

By March 30, 2020April 29th, 2020No Comments

Dermatology News

Featured Article

Dermatologist looking at skin

"Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?"

While the world lives under the shadow of the novel coronavirus (COVID-19) pandemic, dermatologists wonder if the current situation calls for a temporary change in the management of skin conditions.

Immunosuppressive drugs are used ubiquitously in the modern treatment of inflammatory and autoimmune skin diseases like psoriasis, bullous diseases, connective tissue diseases, and many others. Treatment of these conditions is based on the suppression of the patient’s immune system using steroids, steroid-sparing drugs, and biological agents.1
“The use of immunosuppressive to treat these conditions can amplify this effect, and it might leave the patient vulnerable to more serious complications should an infection with the novel coronavirus be established. Hence, it may be wise to restrict temporarily the use of immunosuppressive agents including systemic steroids, steroid-sparing agents, and biologics in dermatology daily practice until more evidence is avilable about their safety in the current pandemic.6 As a relates point, the International Psoriasis Council declared an urgent statement on March 11, 2020 that the physician should be alert to the potentially harmful effects of COVID-19 infection on patients with psoriasis and to immediately discontinue or postpone immunosuppressant medications for psoriasis patients diagnosed with COVID-19 disease.”

As the declaration of the novel coronavirus as a pandemic by the WHO is a trending topic nowadays, dermatologists around the world view with concern the impact of this pandemic on their daily practice.

Read Full Article Now

You May Also Like

Journal of Drugs in Dermatology JDD featuring The Influence of Dermatologists’ Use of Social Media on Attracting PatientsFeatured ArticlesLatest NewsGLP-1 Therapies and Dermatology: A Brief Guide
May 7, 2026

GLP-1 Therapies and Dermatology: A Brief Guide

JDD coverage and what to read next JDD has published an increasing number of articles that examine the connections between GLP-1 therapies and skin health. As GLP-1 receptor agonists gain…
https://jddonline.com/articles/the-influence-of-dermatologists-use-of-social-media-on-attracting-patients-S1545961620P0532X/Featured ArticlesLatest NewsThe Influence of Dermatologists’ Use of Social Media on Attracting Patients
May 6, 2026

The Influence of Dermatologists’ Use of Social Media on Attracting Patients

From the Vault: Patient reviews, clinical experience, and original medical content outweigh social media presence for most patients From the JDD Vault, this cross sectional survey provides timely insight into…
Journal of Drugs in Dermatology JDD featuring Podcast Refresher: Have You Listened To These Episodes?Featured ArticlesLatest NewsPodcast Refresher: Have You Listened To These Episodes?
May 5, 2026

Podcast Refresher: Have You Listened To These Episodes?

Practical insights on topical therapy, pruritus, psoriasis, and off label strategies with Dr. Adam Friedman From steroid safety to itch management to creative on and off label topical strategies and…

Leave a Reply